Neurocrine posts $1.1 billion quarter, raises INGREZZA sales guidanceNov 2Quarterly updateNeurocrine Biosciencesvalbenazine
Neurocrine Biosciences: INGREZZA (NDA209241) SUPPL 34 approvedOct 23Regulatory decisionNeurocrine BiosciencesvalbenazineRecord notice
Neurocrine reports Q2 2026 results, raises INGREZZA guidance, cites 2027 pipeline readoutsJul 30Quarterly updateNeurocrine Biosciencesvalbenazine